GMP Manufactured Product
*Low Bioburden, Low Endotoxin
L-Cystine is a dimer of two Cysteine residues and is a non-essential amino acid. It is synthesized from non-animal derived raw materials under appropriate controls for use in Pharm and Bio-Pharm production under a fully validated GMP manufacturing system. It is also suitable for cell culture media component for the commercial biomanufacturer of therapeutic recombinant proteins and monoclonal antibodies.
CAS #: 30925-07-6
Formula: C6H12N2O4S2·2HCl
MDL Number: MFC00070399
EC#: 250-391-9
F.W.: 313.22 g/mol
| ANALYSIS | SPECIFICATIONS | ||
|---|---|---|---|
|
White to Slightly Yellow Crystalline Powder | ||
|
98.0% - 102.0% | ||
|
≤ 100 CFU/g | ||
|
22.2% - 23.5% | ||
|
<0.02 EU/mg | ||
| Heavy Metals (Pb) |
<10 ppm |
||
|
Passes Test |
||
|
0.5% max. | ||
|
Report | ||
|
≤ 0.1% | ||
|
-225.0° to -215.0° | ||
| Solubility | Passes Test |
Printable Version
Form: Solid
Color: White to Pale Yellow
Melting Point: 228-232 oC
Relative Density:1.5178 g/cm3at 20oC
Soluble in Water
Bio Pharma Grade L-Cystine DiHydrochloride LCYS-4250 is suitable for use as a process chemical. It is GMP manufactured by the approved supplier in accordance with the approved supplier’s ISO 9001:2015 certified management system. This grade of L-Cystine DiHydrochloride is not suitable to be used as an Active Pharmaceutical Ingredient, Drug, Drug Product or Household Item.
The recommended retest period for L-Cystine dihydrochloride is two years from the date of manufacture.
Keep away from heat. Keep away from sources of ignition. Keep container tightly closed, store in a dry and well ventilated place.
Hazardous Statements:
H315 - Causes skin irritation
H320 - Causes eye irritation
10kg and 25kg pails
India
American Manufactured - FDA Registered GMP Facilities: Parenteral Excipients, GMP Small Molecule Intermediates, GMP Biological Buffers, Parenteral Carbohydrates, GMP Chlorinated Amino Acids, GMP Solutions in Sterile Single Use Packaging and other Reagent & GMP Fine Chemicals.